Has Jaime Rivera-Babilonia, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,388 in general payments to Jaime Rivera-Babilonia, MD across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jaime Rivera-Babilonia, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jaime Rivera-Babilonia, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jaime Rivera-Babilonia, MD

Interventional Cardiology · San Juan, PRNPI 1174986129

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,184 of the $7,388 with a category attached, or 70.2%. 13 manufacturers reported payments, led by Abbott at 50.1% of the total. Reporting peaked in 2023 at $2,755 and has fallen 83.5% since, to $454 in 2025. That places this record below the midpoint for interventional cardiology clinicians in PR, where the typical reported total is $12,032.

$7,388in general payments, 2019–2025

Across 97 payments — averaging $76.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Medtronic$2K
Boston Scientific$783
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$307
Shockwave Medical, Inc$193
E.r. Squibb & Sons, L.L.C.$150
plus $532 from 7 others

What the payments were for

Travel & lodging$1,98027%
Food & beverage$5,18470%
Education$1492%
Gifts$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	26	$3,703
Medtronic	22	$1,721
Boston Scientific	24	$783
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	12	$307
Shockwave Medical, Inc	2	$193
E.r. Squibb & Sons, L.L.C.	2	$150
Cordis US CORP.	2	$120
Amgen	1	$119
Cathworks, Inc.	1	$84
Penumbra, Inc.	2	$83
Chiesi USA, Inc.	1	$75
Abiomed	1	$26
PBG Puerto Rico LLC	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPTIS$1,619
SUPERA$1,219
SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY$180
Reveal LINQ$165
Azure$152
Cobalt$149
RESOLUTE ONYX$149
GALLANT$136
COBALT DR MRI SURESCAN$135
ELIQUIS$125
Micra$123
MAMBA$121
Repatha$119
SYMPLICITY G3$111
NA$109
GENERAL TACHY$108
MYNX CONTROL$102
LifeVest$100

How this compares

$7,388 in reported general payments places this provider in the 30th percentile of 39 interventional cardiology providers in Puerto Rico.

See all interventional cardiology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$9,089

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FarxigaDapagliflozin Propanediol	92	$60,515
EliquisApixaban	26	$20,278
EntrestoSacubitril/Valsartan	21	$16,632
BrilintaTicagrelor	30	$16,435
Atorvastatin Calcium	212	$2,037
ClopidogrelClopidogrel Bisulfate	198	$1,875
Metoprolol Succinate	154	$1,717
Rosuvastatin Calcium	83	$793
Losartan Potassium	107	$766
Spironolactone	89	$761
Carvedilol	94	$705
Isosorbide Mononitrate ErIsosorbide Mononitrate	47	$556
Lisinopril	79	$355
Amlodipine Besylate	83	$338
Irbesartan	18	$307

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in San Juan

Damian Grovas AbadSan Juan$498K
Eric Carro JimenezSan Juan$416K
Edwin I Perez MarreroSan Juan$129K
Miguel Campos EsteveSan Juan$8K
Carlos Vazquez SosaSan Juan$4K
Felix Lugo AdamsSan Juan$2K
Orlando RodriguezSan Juan$366
Hector Martinez GonzalezMayaguez$261K
Alejandro Lopez MasPonce$142K
Ricardo SantiagoManati$131K

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →